Search - tctmd.com

Displaying 581 - 600 of 9980

Sort: Relevancy | Date

Presentation NY Valves 2025

Pivot Extend: First-in-Human Application of a Novel Spacer for Treatment of Tricuspid Regurgitation

Presenter: Fabian Barbieri

June 25, 2025

Presentation NY Valves 2025

Percutaneous Treatment of Mitral Leaflet Perforation in a Patient With Incomplete Shone Complex

Presenter: Fernando Pasin

June 25, 2025

Presentation NY Valves 2025

A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)

Presenter: JoAnn Lindenfeld

June 25, 2025

Presentation NY Valves 2025

Successful Treatment of MAC Patient With Atrial Fixation TMVR Who Is Unsuitable Candidate for Surgery, TEER and Sub-valvular TMVR

Presenter: Guilherme Attizzani

June 25, 2025

Presentation NY Valves 2025

MITRA-HR: TEER vs. Surgical Repair in High-Risk Patients

Presenter: Erwan Donal

June 25, 2025

Presentation NY Valves 2025

Case Planning with Artificial Intelligence (Feops, DASI Simulations)

Presenter: Anene Ukaigwe

June 25, 2025

Presentation NY Valves 2025

PRIMARY Trial: TEER vs. Surgical Repair in All-Comers

Presenter: Patrick T. O'Gara

June 25, 2025

Presentation NY Valves 2025

REPAIR-MR: TEER vs. Surgical Repair in Intermediate-Risk Patients

Presenter: Rahul Prakash Sharma

June 25, 2025

Presentation NY Valves 2025

Coronary Versus Commissural Alignment: Consideration for Late Coronary Access

Presenter: Ignacio J. Amat-Santos

June 25, 2025

Presentation NY Valves 2025

Should All Bicuspids Undergo Aggressive Predilation

Presenter: John K. Forrest

June 25, 2025

Presentation NY Valves 2025

The Reality of MR Recurrence After Mitral-TEER

Presenter: D. Scott Lim

June 25, 2025

Presentation NY Valves 2025

Annular Versus Supra-Annular Sizing: My Algorithm for Picking A Smaller THV?

Presenter: Kentaro Hayashida

June 25, 2025

Presentation NY Valves 2025

The Reality of MR Recurrence After Surgical Mitral Valve Repair

Presenter: Vinayak N. Bapat

June 25, 2025

Presentation NY Valves 2025

Age Considerations for Aortic Progression with BAV: When Is TAVR Still Acceptable?

Presenter: Melissa Levack

June 25, 2025

Presentation NY Valves 2025

Current Trends in Primary MR Treatment Alternatives

Presenter: Arnar Geirsson

June 25, 2025

Presentation NY Valves 2025

CT Determinants of TAVR Risk: When Should I Treat with TAVR and When Should I Avoid?

Presenter: Hasan Jilaihawi

June 25, 2025

Presentation NY Valves 2025

Case Presentation: Severe MR in a 65-Year-Old Patient With Mild Symptoms and Barlow’s Disease

Presenter: William Merhi

June 25, 2025

Presentation NY Valves 2025

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Presenter: Martin Maron

June 25, 2025

Presentation NY Valves 2025

Treatment for Mal-positioned Evoque’s Central TR

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

Rare Case of Aorto-Left Atrial Fistula Closure With Amplatzer Duct Occluder II

Presenter: Abhideep Singh

June 25, 2025

Advertisement

Pivot Extend: First-in-Human Application of a Novel Spacer for Treatment of Tricuspid Regurgitation

Percutaneous Treatment of Mitral Leaflet Perforation in a Patient With Incomplete Shone Complex

A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)

Successful Treatment of MAC Patient With Atrial Fixation TMVR Who Is Unsuitable Candidate for Surgery, TEER and Sub-valvular TMVR

MITRA-HR: TEER vs. Surgical Repair in High-Risk Patients

Case Planning with Artificial Intelligence (Feops, DASI Simulations)

PRIMARY Trial: TEER vs. Surgical Repair in All-Comers

REPAIR-MR: TEER vs. Surgical Repair in Intermediate-Risk Patients

Coronary Versus Commissural Alignment: Consideration for Late Coronary Access

Should All Bicuspids Undergo Aggressive Predilation

The Reality of MR Recurrence After Mitral-TEER

Annular Versus Supra-Annular Sizing: My Algorithm for Picking A Smaller THV?

The Reality of MR Recurrence After Surgical Mitral Valve Repair

Age Considerations for Aortic Progression with BAV: When Is TAVR Still Acceptable?

Current Trends in Primary MR Treatment Alternatives

CT Determinants of TAVR Risk: When Should I Treat with TAVR and When Should I Avoid?

Case Presentation: Severe MR in a 65-Year-Old Patient With Mild Symptoms and Barlow’s Disease

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Treatment for Mal-positioned Evoque’s Central TR

Rare Case of Aorto-Left Atrial Fistula Closure With Amplatzer Duct Occluder II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content